Ali Bayram
Ali Bayram, MD, is an Associate Professor in the Department of Otolaryngology–Head and Neck Surgery at the University of Health Sciences, Kayseri Faculty of Medicine, Türkiye. He completed his medical education and residency training at Erciyes University.
Dr. Bayram has extensive clinical experience in head and neck surgery and has participated in several national and international observerships. His academic interests include head and neck oncology, otology, and scientific publishing.
He has authored numerous national and international publications and book chapters, contributing actively to the scientific literature in otorhinolaryngology. Dr. Bayram also serves as an Associate Editor of the Turkish Archives of Otorhinolaryngology and has been a reviewer for multiple international journals.
In addition to his academic and editorial roles, he is actively involved in professional organizations and currently serves as the Vice President of the Turkish School of Head-Neck and Thyroid Surgery.
Sessions
This course is about the silent coordination of swallowing: understanding the clinical sign and detecting the disorder”
The panel aims to present interactive clinical cases of parotid gland malignancy wiyh different stages and discuss with experts which is most appropriate treatment.
Locally invasive thyroid cancer is an uncommon diseaseprocess, which carries significant morbidity and mortality.Current treatment modalities include appropriate surgery, radioactive iodine treatment and external beam radiation therapy.
i will be presenting multiple cases diagnosed with advanced thyroid carcinoma . I will discuss with the panelist thier approaches in managment of such cases.
see attached file ( radiology of the cases )
Thyroid cancer represents one of the most common endocrine malignancies. Its management has evolved substantially with improvements in high-resolution ultrasonography, ultrasound-guided fine-needle aspiration, molecular diagnostics, advanced thyroid surgery, radioactive iodine therapy, targeted systemic therapy, and multidisciplinary care.
the 2025 american thyroid association (ATA) guidelines emphasize individualized management based on diagnosis, risk assessment, treatment selection, and assessment of response to therapy. They also support appropriate de-escalation of treatment in selected low-risk patients, including lobectomy and active surveillance in carefully selected cases.
the 2022 WHO classification has also introduced important changes in thyroid tumor nomenclature and grading, including recognition of differentiated high-grade thyroid carcinoma and revised classification of several follicular-cell-derived tumors
.A tertiary hospital in jordan can provide an integrated thyroid cancer service incorporating endocrine surgery, endocrinology, radiology, pathology, nuclear medicine, oncology, and radiation oncology.
IONM represents a valuable adjunct to meticulous surgical technique and direct visual identification of the RLN in thyroid cancer surgery. Its potential value is particularly relevant in high-risk procedures, including total thyroidectomy, completion thyroidectomy, reoperative surgery, extensive central or lateral neck dissection, and locally invasive thyroid cancer. Establishing a standardized IONM-based thyroid cancer pathway in a tertiary hospital in jordan may improve nerve-risk assessment, facilitate intraoperative decision-making, and provide objective data regarding RLN function and postoperative voice outcomes. This study will provide important local data and may serve as a foundation for establishing a national multidisciplinary thyroid cancer surgical registry in jordan.